SCHEMBL9898781

SCHEMBL9898781

CCCCc1ccc(-c2cc(Nc3ccccc3)ccc2-c2ccc(Nc3ccccc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.46
HSD11B1 P28845 2/20 0.44
APP P05067 1/20 0.42
MAPT P10636 4/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
ALOX12 P18054 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
PSMB5 P28074 1/20 0.42
RARB P10826 3/20 0.41
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29977076 1.00 TRPV1 (0.46) TRPV1HSD11B1APPMAPTHPGD
SCHEMBL3990792 0.97 TRPV1 (0.46) TRPV1HSD11B1APPMAPTHPGD
SCHEMBL1726974 0.93 TRPV1 (0.43) TRPV1HSD11B1APPMAPTHPGD
SCHEMBL2207287 0.88 NPSR1 (0.45) TRPV1HSD11B1MAPTHPGDSMN1; SMN2
SCHEMBL5617645 0.87 APP (0.42) HSD11B1APPMAPTHPGDSMN1; SMN2
SCHEMBL24570956 0.85 MAPT (0.55) TRPV1HSD11B1MAPTHPGDSMN1; SMN2
SCHEMBL2539187 0.84 TRPV1 (0.58) TRPV1HSD11B1MAPTHPGDSMN1; SMN2
SCHEMBL4358262 0.84 MEN1 (0.41) TRPV1HSD11B1MAPTHPGDSMN1; SMN2
SCHEMBL13519493 0.84 HSD11B1 (0.42) TRPV1HSD11B1MAPTHPGDSMN1; SMN2
SCHEMBL5012296 0.84 UCHL3 (0.44) MAPTHPGDSMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023165240-A1 PREPARATION METHOD OF NANO ZINC OXIDE SOLUTION, PHOTOELECTRIC DEVICE, AND DISPLAY APPARATUS TCL科技集团股份有限公司 2023-09-07 WO claimed
WO-2023142556-A1 METHOD FOR PREPARING ZINC OXIDE NANOCRYSTAL, PHOTOELECTRIC DEVICE, AND DISPLAY APPARATUS TCL科技集团股份有限公司 2023-08-03 WO claimed
US-20120146006-A1 MATERIAL FOR A HOLE TRANSPORT LAYER WITH P-DOPANT NOVALED GMBH (DE) 2012-06-14 US claimed
WO-2023202151-A1 FILM LAYER OF LIGHT EMITTING DIODE AND FILM FORMING METHOD THEREFOR, AND LIGHT EMITTING DIODE TCL科技集团股份有限公司 2023-10-26 WO disclosed
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
WO-2023142556-A1 METHOD FOR PREPARING ZINC OXIDE NANOCRYSTAL, PHOTOELECTRIC DEVICE, AND DISPLAY APPARATUS TCL科技集团股份有限公司 2023-08-03 WO disclosed
WO-2023111753-A1 PHOTOELECTRIC CONVERSION DEVICE, DISPLAY APPARATUS, DISPLAY MODULE, AND ELECTRONIC EQUIPMENT 株式会社半導体エネルギー研究所 2023-06-22 WO disclosed
WO-2023098371-A1 PHOTOELECTRIC DEVICE PROCESSING METHOD AND PHOTOELECTRIC DEVICE TCL科技集团股份有限公司 2023-06-08 WO disclosed
EP-3183757-B1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM CLAP CO LTD (KR) 2022-05-04 EP disclosed
US-10454037-B2 Organic semiconductor composition comprising a liquid medium BASF SE (DE) 2019-10-22 US disclosed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US disclosed
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM BASF SE (DE) 2017-08-31 US disclosed
US-20170237005-A1 PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2017-08-17 US disclosed
EP-3183757-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM BASF SE (DE) 2017-06-28 EP disclosed
EP-3183250-A1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2017-06-28 EP disclosed
WO-2016027218-A1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2016-02-25 WO disclosed
WO-2016027217-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM BASF SE (DE) 2016-02-25 WO disclosed
WO-2015059647-A1 CRYSTALLINE FORM OF N,N'-BIS-(HEPTAFLUOROBUTYL)-2,6-DICHLORO-1,4,5,8-NAPHTHALENE TETRACARBOXYLIC DIIMIDE AND THE USE THEREOF BASF SE (DE) 2015-04-30 WO disclosed
US-8610113-B2 Material for a hole transport layer with p-dopant SIEMENS AKTIENGESELLSCHAFT (DE) 2013-12-17 US disclosed
US-20120146006-A1 MATERIAL FOR A HOLE TRANSPORT LAYER WITH P-DOPANT NOVALED GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM CRY1, NEFM, OR10J3 TRPV1 603/4885HSD11B1 4549/4885APP 2705/4885
US-10454037-B2 Organic semiconductor composition comprising a liquid medium CRY1, NEFM, OR10J3 TRPV1 603/4885HSD11B1 4549/4885APP 2705/4885
US-10224485-B2 Process for preparing a crystalline organic semiconductor material STOM, SPOP, TTR TRPV1 2357/4885HSD11B1 2691/4885APP 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.